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Abstract The CRISPR-Cas9 targeted nuclease technology allows the insertion of genetic
modifications with single base-pair precision. The preference of mammalian cells to repair Cas9-
induced DNA double-strand breaks via error-prone end-joining pathways rather than via homology-
directed repair mechanisms, however, leads to relatively low rates of precise editing from donor
DNA. Here we show that spatial and temporal co-localization of the donor template and Cas9 via
covalent linkage increases the correction rates up to 24-fold, and demonstrate that the effect is
mainly caused by an increase of donor template concentration in the nucleus. Enhanced correction
rates were observed in multiple cell types and on different genomic loci, suggesting that covalently
linking the donor template to the Cas9 complex provides advantages for clinical applications where
high-fidelity repair is desired.
DOI: https://doi.org/10.7554/eLife.33761.001
Introduction
The CRISPR-Cas9 system is a versatile genome-editing tool that enables the introduction of site-spe-
cific genetic modifications (Jinek et al., 2012). In its most widespread variant a programmable chi-
meric single guide RNA (sgRNA) directs the Cas9 nuclease to the genomic region of interest, where
it generates a site-specific DNA double-strand break (DSB) (Mali et al., 2013). In mammalian cells
the repair of DSBs by different end-joining (EJ) pathways, such as classical non-homologous end join-
ing (c-NHEJ), alternative non-homologous end-joining (a-NHEJ), or single-strand annealing (SSA)
often leads to the formation of insertions or deletions (indels) (Shalem et al., 2014; Ceccaldi et al.,
2016). Alternatively, when a donor template is provided, mammalian cells can also resolve DSBs via
homology-directed repair (HDR) mechanisms, such as the classical homologous recombination (HR)
pathway (Mao et al., 2008) and the Fanconi Anemia (FA) repair pathway (Richardson, 2017). While
the formation of indels allows the elimination of gene function, repair from an ectopic donor oliogo-
nucleotide (oligo) via HDR mechanisms enables the introduction of DNA modifications with single
base pair precision (van den Bosch et al., 2002).
Therapeutic applications of CRISPR-Cas9 generally require the precise correction of pathogenic
mutations using donor templates. However, DSBs introduced in mammalian cells are predominantly
repaired by error-prone EJ pathways. As the resulting indels inhibit the CRISPR-Cas9 complex from
retargeting the locus, error-prone repair indirectly competes with HDR, and therefore reduces the
rates of precise correction from donor templates. Furthermore, if the targeted allele is a hypomorph
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with residual gene function, the generated indels can further worsen the clinical phenotype of the
disease (Chu et al., 2015). In recent years, several attempts have therefore been made to enhance
HDR-mediated correction of CRISPR-Cas9-induced DSBs from donor oligos. Based on the knowl-
edge that HDR pathways are primarily active during the S/G2 phase of the cell cycle, cells have been
synchronized prior to CRISPR-Cas9 delivery (Lin et al., 2014a), and Cas9 expression has been lim-
ited to the S/G2/M phase of the cell cycle (Gutschner et al., 2016; Howden et al., 2016). Other
studies have increased HDR by chemically modulating the EJ and HDR pathways (Chu et al., 2015;
Maruyama et al., 2015; Yu et al., 2015; Song et al., 2016), and by rationally designing DNA repair
templates with optimal homology arm lengths (Richardson et al., 2016). In addition, it has been
proposed that the availability of the DNA repair template might present a rate-limiting factor for
eLife digest Genome editing allows scientists to change an organism’s genetic information by
adding, replacing or removing sections of its DNA sequence. The CRISPR-Cas9 system is a genome-
editing tool that has had a large impact on biological research in recent years, and also shows
promise for the treatment of patients with genetic disorders.
The tool works as follows: a small piece of RNA (a close cousin to DNA) is used to guide an
enzyme called the Cas9 endonuclease to the desired region of the genome. Then, like a pair of
molecular scissors, the enzyme cuts the DNA, breaking both strands of its double helix. The cell
naturally starts to repair the damaged DNA, and one way to do this is to use another similar piece of
intact DNA as a template. Scientists can exploit this repair mechanism (known as homology-directed
repair) by giving the cell extra DNA that carries their desired sequence change, with the hope that
the cell will use it as a template and edit its own genome in precisely the same way. However, it
turns out that mammalian cells rarely use the template DNA to repair the damage. Instead,
mammals tend to fix double-stranded breaks in DNA by simply joining the broken ends together, a
method that is prone to errors.
To overcome this specific issue, Savic, Ringnalda et al. tested the effect of physically linking the
template DNA to the Cas9 enzyme, so that the DNA was already nearby when the enzyme made
the cut. Experiments with human cells confirmed that this new approach increased the frequency of
homology-directed repair up to 24-fold compared to leaving the enzyme and the template DNA
separate. Improving the CRISPR-Cas9 system in this manner makes it more likely that genome
editing may one day become a routine treatment for patients with genetic disorders. But first, more
preclinical studies are needed to assess the safety of the CRISPR-Cas9 technology for gene editing
in patients.
DOI: https://doi.org/10.7554/eLife.33761.002
Figure 1. Schematic overview of the workflow for linking the DNA repair template to the Cas9 RNP complex. O6-benzylguanine (BG)-labeled DNA
oligos are covalently linked to Cas9-SNAP fusion proteins. The DNA-Cas9 molecules are then complexed with the specific sgRNAs to form the
functional ribonucleoprotein-DNA (RNPD) complexes.
DOI: https://doi.org/10.7554/eLife.33761.003
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Figure 2. Fluorescent reporter system for high-throughput analysis of DSB repair rates. (a) Schematic overview of
the HEK293T fluorescent reporter system. The RFP fluorophore carries a c.190_191delinsCT mutation that
substitutes two nucleotides TA at the positions 190 and 191 in the RFP sequence to CT. This leads to the
inactivation the RFP fluorophore by the substitution of tyrosine at the position 63 with leucine (p.Y63L). Repair of
the mutation via donor oligos generates RFP/GFP double positive cells; indel mutations generate RFP/GFP double
negative cells if they induce a frame shift. Of note, analysis of the reporter locus by next generation sequencing
(NGS) demonstrated that 20 percent of indels did not lead to a frame shift (Supplementary file 4). Nevertheless,
Figure 2 continued on next page
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Figure 2 continued
although FACS analysis thereby underestimates the absolute number of edited cells, it allows to accurately
compare the correction efficiencies of different Cas9 systems. ‘X’ labels the mutation in RFP. 2A stands for 2A ‘self-
cleaving’ peptide (Kim et al., 2011). (b) Schematic overview of the Streptococcus pyogenes sgRNA targeting
mutRFP fluorophore and the corresponding PAM site. Black arrow indicates the introduced DSB site. The two
nucleotides in the sgRNA seed sequence as well as the amino acid in the fluorophore region that are changed
upon of precise repair (CT >TA and L > Y) are shown in orange. (c) Correction and indel rates can be quantified by
FACS. The panels show FACS plots for gating GFP negative cells (upper panel) and the RFP positive cells (lower
panel). (d) Representative confocal microscopy images. Scale bar: 50 mm, magnification 20x. Live cell nuclei were
stained with Hoechst 33342. The efficiency of the sgRNA (sgRNASpCas9(mutRFP)) is shown in Figure 3—figure
supplement 1b.
DOI: https://doi.org/10.7554/eLife.33761.004
Figure 3. Covalent linkage of the DNA repair template to the Cas9 RNP complex. (a) Band shift of the 81-mer amino-modified oligo after coupling to
BG-GLA-NHS shown on a denaturing PAGE gel. Amino modified oligos were mixed with amine-reactive BG building blocks and the samples were
taken prior to the reaction (uncoupled) and after the reaction (coupled). No BG coupling: no amine-reactive BG building block was added to the amino
modified oligos. (b) LC-MS analysis of HPLC-purified BG-coupled and uncoupled DNA repair templates. (c,d) Coomassie Blue stained SDS-PAGE gels
of the purified SpCas9-SNAP and the SadCas9-SNAP fusion proteins (functionality of the SNAP-tags is shown in Figure 3—figure supplement 1e,f). (e-
h) Silver stained SDS-PAGE gels. Band shifts confirm covalent linkage of Cas9-SNAP proteins to BG-coupled 81-mers. Lower arrowheads: unbound
Cas9-SNAP. Upper arrowheads: Cas9-SNAP covalently bound to oligos.
DOI: https://doi.org/10.7554/eLife.33761.005
The following source data and figure supplement are available for figure 3:
Source data 1. Numerical data and the exact p values for all graphs in Figure 3—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.33761.007
Figure supplement 1. Covalent linkage of the DNA repair template to the Cas9 RNP complex.
DOI: https://doi.org/10.7554/eLife.33761.006
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Figure 4. Linking the repair template to the Cas9 RNP complex enhances correction efficiency in a fluorescent reporter cell line. (a) Comparison
between the control Cas9 system (RNP unco.: SpCas9-SNAP plus unlabeled donor oligo) and our novel system (RNPD coup.: SpCas9-SNAP conjugated
to BG-labeled donor oligo). Cells were analyzed 5 days after transfection by FACS. Results are presented as correction efficiency (percentage of
correction in edited cells). (b) Illustration of our novel Cas9 system, in which the repair template is covalently bound to SpCas9-SNAP (RNPD coup.). (c)
Schematic overview of the binding positions of different SadCas9 sgRNAs (sgRNAsSadCas9(mutRFP)-1-4) in comparison to the SpCas9 sgRNA targeting
the mutRFP fluorophore (sgRNAsSpCas9(mutRFP)). (d) Illustration of the two-component system, where the repair template is linked to the catalytically
inactive SadCas9-SNAP (RNP-RNPD coup.). (e) Comparison between the two-component system (RNP-RNPD coup.: SpCas9-SNAP + SadCas9-
Figure 4 continued on next page
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HDR, and that enhancing the local concentration of donor oligos could increase the correction rates
(Ruff et al., 2014; Carlson-Stevermer et al., 2017). Based on this hypothesis, we here generated
and tested novel CRISPR-Cas9 variants, in which the DNA repair template is covalently conjugated
to Cas9 (Figure 1).
Results and discussion
To be able to measure HDR efficiencies of novel CRISPR-Cas9 variants in a rapid and high-through-
put manner, we first generated a fluorescent reporter system (Figure 2a–b). In brief, the reporter
cassette was stably integrated in HEK293T cells, and expresses a green fluorescent protein (GFP)
that is preceded by an inactive mutant version of a red fluorescent protein (mutRFP). While precise
correction of the mutation via HDR from donor templates leads to re-activation of RFP activity, the
generation of frame shifts via error-prone EJ pathways leads to loss of GFP activity (Figure 2a–b).
The correction and indel formation events can be visualized by fluorescence imaging and quantified
by FACS (Figure 2c–d). To test the functionality of the reporter system, and to determine the opti-
mal length of DNA repair templates, we first transfected Cas9-sgRNA ribonucleoprotein (RNP) com-
plexes and single stranded (ss) oligo repair templates of different lengths (Figure 3—figure
supplement 1a). In line with previous studies (Zuo et al., 2017), we found that maximal DSB correc-
tion rates are reached with ss-donor oligos of approximately 80 bases. We therefore continued our
study with 81-nucleotide (81-mers) ss-donor oligos but also included 65-nucleotide (65-mers) oligos,
as we reasoned that if repair templates are brought in proximity to DSBs also shorter homology
arms could be sufficient for HDR.
In order to link the donor oligos to the Cas9 protein, we used the SNAP-tag technology, which
allows covalent binding of O6-benzylguanine (BG)-labeled molecules to SNAP-tag fusion proteins
(Keppler et al., 2003). To generate O6-benzylguanine (BG)-linked DNA repair templates, we first
coupled amine-modified oligos to commercially available amine-reactive BG building blocks
(Figure 3a, Figure 3—figure supplement 1c). The BG-linked oligos were further separated from
unreacted oligos by HPLC (Figure 3b) and analyzed by liquid chromatography-mass spectrometry
(LC-MS) to confirm their purity (Figure 3—figure supplement 1d). Next, we produced recombinant
Cas9 proteins with a SNAP-tag fused to the C-terminus (Figure 3c,d). The fusion proteins were then
complexed with the BG-coupled oligos, and covalent binding was confirmed by SDS-PAGE
(Figure 3e–h). The protein-oligo conjugate was mixed with in vitro transcribed sgRNAs targeting the
Figure 4 continued
SNAP bound to BG-labeled donor oligo) and the corresponding control Cas9 system (RNP-RNP unco.: SpCas9-SNAP + SadCas9-SNAP + unlabeled
repair oligo). (f) Transfection of the one component system (grey and pink panels) and two component system (black/grey and black/pink panels) into
reporter cells at a 5-time lower concentrations. In the two component system sgRNASadCas9(mutRFP)-3 was used. (g) Comparison of two component
systems with and without the sgRNA for the SadCas9 complex. RNP unco. (SpCas9-SNAP + uncoupled oligo + sgRNASpCas9(mutRFP)); RNPD coup.
(SpCas9-SNAP-coupled BG-oligo + sgRNASpCas9(mutRFP)); RNP-RNP unco. (SpCas9-SNAP + sgRNASpCas9(mutRFP) + SadCas9-SNAP + uncoupled
oligo + sgRNASadCas9(mutRFP)); RNP-RNPD coup. (SpCas9-SNAP + sgRNASpCas9(mutRFP) + SadCas9-SNAP-coupled BG-oligo +
sgRNASadCas9(mutRFP)). All values are shown as mean ±s.e.m of biological replicates; *p<0.0332 with n = 3 (f) and n = 4 (a,e,g) (n represents the
number of biological replicates). A one-tailed Mann-Whitney test was used for comparisons. Numerical data and the exact p values for all graphs are
shown in the Figure 4—source data 1.
DOI: https://doi.org/10.7554/eLife.33761.008
The following source data and figure supplements are available for figure 4:
Source data 1. Numerical data and the exact p values for all graphs in Figure 4.
DOI: https://doi.org/10.7554/eLife.33761.011
Source data 2. Numerical data for all graphs in Figure 4—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.33761.012
Source data 3. Numerical data and the exact p values for all graphs in Figure 4—figure supplement 2.
DOI: https://doi.org/10.7554/eLife.33761.013
Figure supplement 1. Linking the repair template to the Cas9 RNP complex increases correction rates at the expense of indel formation.
DOI: https://doi.org/10.7554/eLife.33761.009
Figure supplement 2. Mechanistic insights into enhanced correction rates.
DOI: https://doi.org/10.7554/eLife.33761.010
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mutRFP locus (Figure 3—figure supplement 1g,h), finally generating the Cas9 ribonucleoprotein-
DNA (RNPD) complex.
To test if linking the donor oligo to Cas9 changes the ratio between indel formation and correc-
tion from the repair template, we used our reporter system to compare Streptococcus pyogenes
Cas9 (SpCas9) complexes with linked repair oligos (Figure 4b) to the control SpCas9 complexes
with unlinked repair oligos (SpCas9-SNAP with unlabeled oligos). Notably, the correction efficiency
(percentage of corrections in edited cells) with bound complexes was significantly enhanced, from
2.1% to 22.5% with the 65-mers and from 8.9% to 25.7% with the 81-mers (Figure 4a, Figure 4—fig-
ure supplement 1a,b). In comparison to unbound complexes this represented 11- and 3-fold
increases, respectively.
To further test our hypothesis that spatial and temporal co-localization of repair templates and
Cas9 enhances correction rates, we next developed an independent approach where the donor
oligo is not bound to the Cas9 complex that induces the DSB, but to a second catalytically inactive
Cas9 complex that binds in close proximity to the DSB (RNP-RNPD system). To avoid the inter-
change of sgRNAs between both complexes, we designed a two-component system in which the
DSB is induced by SpCas9, and the repair template is linked to a catalytically inactive Staphylococcus
aureus (Sa)dCas9 (Figure 4c,d). We co-transfected both complexes into the reporter cell line, and
quantified correction and indel formation rates. Notably, the correction efficiency increased from
4.1% to 29.9% with 65-mers, and from 11.6% to 32.3% with 81-mers (Figure 4e, Figure 4—figure
supplement 1c,d), confirming our previous results with the RNPD system.
In vivo, the delivery efficiency of RNPs and oligos is generally lower than in vitro. Thus, if the
repair template is not bound to Cas9, there is a substantial probability that only one of the two com-
ponents would be delivered into the cell. In addition, at lower transfection efficiencies fewer repair
templates are present in the nucleus, potentially decreasing HDR rates. As we presumed that linking
the donor oligo to Cas9 should largely alleviate these limitations, we investigated whether the repair
Figure 5. Linking the repair template to the Cas9 RNP complex enhances correction efficiency at endogenous loci. (a,b,c) Upper panels: Schematic
overview of the target genomic regions of the Streptococcus pyogenes gRNAs. Black arrow indicates the introduced DSB site. The nucleotides that are
exchanged in case of precise repair are shown in blue. Lower panels: NGS data quantification: Correction efficiency of the control Cas9 system (RNP
unco.: SpCas9-SNAP plus unlabeled donor oligo) compared to our novel system (RNPD coup.: SpCas9-SNAP bound to BG-labeled donor oligo) is
shown. (a) The HBB locus was targeted in a K562 cell line. The (b) Rosa26 and (c) Pcsk9 loci were targeted in mouse ESCs. All values are shown as
mean ±s.e.m of biological replicates; *p<0.0332 with n = 4 (a) and n = 3 (b,c) (n represents the number of biological replicates). A one-tailed Mann-
Whitney test was used for comparisons. Allele plots, variant count tables and categorized variant count tables for these loci are available as
Supplementary file 2–4. Numerical data and the exact p values for all graphs are shown in the Figure 5—source data 1.
DOI: https://doi.org/10.7554/eLife.33761.014
The following source data is available for figure 5:
Source data 1. Numerical data and the exact p values for all graphs in Figure 5.
DOI: https://doi.org/10.7554/eLife.33761.015
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Figure 6. Direct comparison of the Cas9 RNPD system to the classical Cas9 complex. Classical Cas9 system (wild type SpCas9 plus unlabeled donor
oligo); Our novel RNPD system (SpCas9-SNAP conjugated to BG-labeled donor oligo). (a) Targeting of the reporter locus in HEK293T cells. Illustration
of the most frequent variants found by NGS in untreated samples (NT), in samples transfected with the classical Cas9 system (65-mer unco. (SpCas9
WT)), and in our engineered system (65-mer coup. (SpCas9-SNAP)). Alleles with a frequency above 0.5% in any of the nine samples are shown. For
alleles with lower frequencies see Supplementary file 3. Abbreviations: Insertion (I), Deletion (D), Single nucleotide variant (SNV). Different colours in
the x-axis indicate the three experimental replicates. A detailed description of the plot labels can be found in the Supplementary File 2 legend. (b,d,e,f)
Figure 6 continued on next page
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efficiency with template-conjugated Cas9 is affected when complexes are transfected at 5-fold lower
concentrations. Importantly, although under these conditions the correction efficiencies were gener-
ally lower with both coupled and uncoupled Cas9 complexes, the difference between the two sys-
tems was however even more pronounced. Compared to the uncoupled RNP complex, the RNPD
system yielded 20-fold and a 4-fold increases in repair efficiency with 65-mer and 81-mer repair tem-
plate oligos, respectively (Figure 4f, Figure 4—figure supplement 1e,f). Similarly, the two-compo-
nent RNP-RNPD system led to a 21-fold increase with 65-mers and a 6-fold increase with 81-mers
(Figure 4f, Figure 4—figure supplement 1e,f). Taken together, our results suggest that linking the
repair template to the Cas9 complex leads to improved correction efficiency compared to the
unlinked control CRISPR-Cas9 system, and that this effect is even more pronounced when CRISPR-
Cas9 components are delivered at lower concentrations.
Next, we aimed to gain mechanistic insight into the processes that lead to enhanced correction
rates when the donor oligo is linked to the Cas9 complex. We first assessed if the BG-labelling of
the donor oligo itself already influences the correction efficiencies, and compared the correction
rates of wild-type SpCas9 lacking the SNAP-tag together with either unlabelled oligo or BG-labelled
oligo. While the correction rates were enhanced when the donor oligo was labelled with BG, the
increase was several fold lower compared to the system where the oligo was conjugated to the Cas9
RNP complex (Figure 4—figure supplement 2a–c). We then investigated if the observed improve-
ment in correction efficiency is due to the donor oligo being brought in close proximity to the DSB,
or if it is sufficient to direct the donor oligo to the nucleoplasm. We therefore again employed the
two-component system with DSB inducing SpCas9 and catalytically inactive SadCas9 conjugated to
the donor oligo. While in one group SadCas9 was complexed with a sgRNA that directs it in close
proximity to the DSB, in the other group the sgRNA was omitted and SadCas9 was therefore only
directed into the nucleus. Importantly, our results demonstrated that adding the sgRNA did not fur-
ther enhance correction rates, suggesting that the increase of donor oligo concentration in the
nucleoplasm was sufficient to fully account for the positive effect of the Cas9-donor oligo
conjugation (Figure 4g, Figure 4—figure supplement 2d,e). In line with these observations, a num-
ber of previous studies demonstrated that exogenous DNA transport into the nucleus is one of the
major barriers to effective gene delivery (Subramanian et al., 1999; Zanta et al., 1999;
Ludtke et al., 1999; Aronsohn and Hughes, 1998).
To validate our results from the HEK293T reporter cells, we next tested our approach at different
endogenous genomic loci and in different cell types. We first targeted the human beta globin (HBB)
locus in the K562 cell line, and analyzed correction and editing frequencies using next generation
sequencing (NGS). The mean correction efficiency with the RNPD system was 19.6%, which repre-
sented a 17-fold increase compared to the control RNP system (Figure 5a, Supplementary file 2).
Next we targeted the Rosa26 and proprotein convertase subtilisin/kexin type 9 (Pcsk9) locus in
mouse embryonic stem cells (mESCs). Again, the mean correction efficiencies of RNPD systems were
significantly increased, to 18.6% at the Rosa26 locus and 23.2% at the Pcsk9 locus (Figure 5b,c,
Supplementary file 2). In comparison to the uncoupled RNP complexes, this represented 2- and 6-
fold increases, respectively.
Figure 6 continued
NGS data quantification of the (b) reporter locus, (d) HBB locus, (e) EMX1, and (f) CXCR4 locus targeted in HEK293T cells. In (a,b,c) the mutRFP sgRNA
(see Figure 2b) was used. (c) Off target analysis for sgRNASpCas9(mutRFP): the percentage of edited alleles detected using NGS in untreated samples,
in samples transfected with the classical Cas9 system, and in our engineered system. Information on the off target loci can be found in
Supplementary file 1 – Supplementary Table 1. (d,e,f) Upper panels: Schematic overview of the target genomic regions of the gRNAs. Black arrow
indicates the introduced DSB site. The nucleotides that are exchanged in case of precise repair are shown in blue. Lower panels: NGS data
quantification. Correction efficiency of the classical Cas9 system compared to our novel system is shown. All values are shown as mean ±s.e.m of
biological replicates. *p<0.0332 with n = 3 (b,c) and n = 4 (d,e,f) (n represents the number of biological replicates). A one-tailed Mann-Whitney test was
used for comparisons. Allele plots, complete variant count tables and categorized variant count tables for these loci are available as
Supplementary file 2–4. Numerical data and the exact p values for all graphs are shown in the Figure 6—source data 1.
DOI: https://doi.org/10.7554/eLife.33761.016
The following source data is available for figure 6:
Source data 1. Numerical data and the exact p values for all graphs in Figure 6.
DOI: https://doi.org/10.7554/eLife.33761.017
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In the previous experiments the RNPD system was always compared to Cas9 SNAP-tag fusion
proteins with uncoupled donor oligos. To also directly compare the engineered RNPD system to the
classical CRISPR-Cas9 system, we performed experiments where we used wild-type Cas9 with the
uncoupled donor oligos as a control. We first targeted the fluorescent reporter locus and analyzed it
by NGS. We found that while the mean percentage of corrected loci increased from 0.8% with the
classical Cas9 system to 4.9% with the RNPD system, the number of incorrectly edited loci slightly
decreased from 12.6% to 9.3% (Figure 6a, Supplementary file 2,3,4). This corresponds to a 7-fold
increase in correction efficiency (Figure 6b). In addition, the analysis of three computationally pre-
dicted off-target sites (Lin et al., 2014b; Cradick et al., 2014) of the reporter locus, suggests that
the risk for generating off-target mutations is not enhanced with the RNPD system (Figure 6c,
Supplementary file 2,3,4). In the next step we also targeted and analyzed the endogenous loci
HBB, empty spiracles homeobox 1 (EMX1), and C-X-C chemokine receptor type 4 (CXCR4) in
HEK293T cells. NGS analysis revealed that in all three loci the mean correction efficiency of the
RNPD system was markedly increased to: 34,4% at the HBB locus, 28.6% at the EMX1 locus and
33.1% at the CXCR4 locus (Figure 6d,e,f, Supplementary file 2,3,4). Compared to the classical
CRISPR-Cas9 system this represents a 20-fold, a 10-fold, and a 24-fold increase, respectively
(Figure 6d,e,f).
Direct delivery of Cas9 RNP complexes into tissues promises great potential for therapeutic appli-
cations. Compared to genetically encoded systems, RNPs avoid the danger of genomic integration,
and due to their limited lifetime, the risk of off-target activities is low (Kim et al., 2014). In addition,
procedures for large-scale production of recombinant proteins for clinical use are well established,
and several recently developed protocols enable in vivo delivery of Cas9 RNP complexes in animal
models (Wang et al., 2016; Zuris et al., 2015; Staahl et al., 2017; Lee et al., 2017). Here, we pres-
ent a method where we enhance correction efficiency of Cas9-induced DSBs by conjugating the
donor oligo to the Cas9 complex. Our data suggests that the increase in HDR efficiency is caused by
enhanced nuclear concentration of the repair template. Unlike previous approaches that increase
HDR rates by chemically modulating DNA repair pathways, our approach does not alter endogenous
cellular processes, thus reducing risk of potential negative side effects. In addition, covalent linkage
of the repair template to the Cas9 RNP complex also addresses another central challenge of in vivo
gene editing therapies – namely that simultaneous delivery of the RNP complex and the repair tem-
plate needs to be ensured. Taken together, we suggest that covalently linking the DNA repair tem-
plate to the Cas9 RNP complex is poised to further drive the CRISPR/Cas technology towards
clinical translation.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Recombinant protein
(Streptococcus pyogenes)
SpCas9-SNAP This paper Schwank and Jinek lab
Recombinant protein
(Staphylococcus aureus)
SadCas9-SNAP This paper Schwank and Jinek lab
Genetic reagent NH2-modified oligo Integrated DNA Technologies - Custom DNA oligos/ ’5 C6
NH2 modif.
Chemical compound BG-GLA-NHS New England Biolabs ID_NEB:S9151S
Please see Supplementary file 1-Supplementary Tables 1–6 for a list of the DNA sequences used in
this manuscript.
Plasmids
All plasmids used in this study (listed in Supplementary file 1-Supplementary Table 6) have been
deposited for the TULIPs system, along with maps and sequences, in Addgene.
Cloning of pNS19-LV-mutRFP-2A-GFP: pEGIP (addgene plasmid #26777) was mutagenized using
QuikChange Lightning Multi Site-Directed Mutagenesis Kit (Agilent Technologies) to destroy the
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start codon of eGFP. Next the vector was linearized with BamHI and In-Fusion HD Cloning Plus CE
(Takara) was used to insert the mutRFP-2A gBlocks Gene Fragment (Integrated DNA Technologies).
Cloning of pNS20-SpCas9-SNAP: pMJ922-SpyCas9-GFP bacterial expression vector was a kind
gift from Prof. Martin Jinek. GFP was digested using BamHI and KpnI, and SNAPtag-NLS gBlocks
(Integrated DNA Technologies) were integrated using In-Fusion HD Cloning Plus CE (Takara).
Cloning of pNS38-SadCas9-SNAP: pAD-SaCas9-GFP was generated by replacing the SpCas9
coding sequence in pMJ922 with SaCas9 sequence using Gibson cloning (Keppler et al., 2003).
QuikChange Lightning Multi Site-Directed Mutagenesis Kit (Agilent Technologies) was used to
remove the stop codon and to introduce the D10A and N580A mutations into the SaCas9 (SadCas9)
gene. Subsequently, GFP was cut out using BamHI and KpnI, and replaced by a SNAP-tag-NLS
gBlock (Integrated DNA Technologies) using In-Fusion HD Cloning Plus CE (Takara).
Plasmid pMJ806 was a gift from Jennifer Doudna (Addgene plasmid # 39312) (Jinek et al.,
2012).
Benzylguanine coupling reaction
Synthetic oligonucleotides with a 50-Amino Modifier C6 functional group (100 mM) (Integrated DNA
Technologies) were incubated with benzylguanine-GLA-NHS (1 mM) (NEB) and Hepes pH8.5
(200mM) for 60 min at 30˚C. Coupling reactions were performed in following ratios: 30:1, 60:1 and
100:1 BG-GLA-NHS: amino modified oligo. After the coupling reaction all oligos were purified by
ethanol precipitation. Repair oligo sequences can be found in Supplementary file 1-Supplementary
Table 4.
Denaturating PAGE
The benzylguanine (BG) coupled reactions were run on 20% polyacrylamide TBE gel containing 8M
urea at 200 V for 60 min. The gel was stained for 30 min in 1x TBE containing Sybr Gold (Invitrogen),
and imaged with a UV transilluminator (Biorad).
HPLC purification and LC-MS analysis of the repair oligos
Benzylguanine coupled oligos were purified on an Agilent 1200 series preparative HPLC fitted with a
Waters XBridge Oligonucleotide BEH C18 column, 10  50 mm, 2.5 mm at 65˚C using a gradient of
5–25% buffer B over 8 min, flow rate = 5 ml min-1. Buffer A was 0.1 M triethylammonium acetate,
pH 8.0. Buffer B was methanol. Fractions were pooled, dried in a speedvac and dissolved in H2O.
Analysis of the purified BG-oligonucleotide was conducted on an Agilent 1200/6130 LC-MS system
fitted with a Waters Acquity UPLC OST C18 column (2.1  50 mm, 1.7 mm) at 65˚C, with a gradient
of 5–35% buffer B in 14 min with a flowrate of 0.3 mL min 1. Buffer A was aqueous hexafluoroiso-
propanol (0.4 M) containing triethylamine (15 mM). Buffer B was methanol.
Expression and purification of Cas9-SNAP
Snap-tagged Streptococcus pyogenes Cas9 (SpCas9-SNAP), Staphylococcus aureus dCas9 (Sad-
Cas9-SNAP) and Wild Type Streptococcus pyogenes Cas9 (SpCas9 WT) proteins were expressed in
Escherichia coli BL21 (DE3) Rosetta 2 (Novagen) fused to an N-terminal fusion protein containing a
hexahistidine affinity tag, the maltose binding protein (MBP) polypeptide sequence, and the tobacco
etch virus (TEV) protease cleavage site. The cells were lysed in 20 mM Tris pH 8.0, 500 mM NaCl, 5
mM Imidazole pH 8.0. Clarified lysate was applied to a 10 ml Ni-NTA (Qiagen) affinity chromatogra-
phy column. The column was washed by increasing the imidazole concentration to 10 mM and
bound protein was eluted in 20 mM Tris pH 8.0, 250 mM NaCl, 100 mM Imidazole pH 8.0. To
remove the His6-MBP affinity tag, the eluted protein was incubated overnight in the presence of TEV
protease. The cleaved protein was further applied to a heparin column (HiTrap Heparin HP, GE
Healthcare) and eluted with a linear gradient of 0.1–1.0 KCl. The eluted protein was further purified
by size exclusion chromatography using a Superdex 200 16/600 (GE Healthcare) equilibrated in 20
mM HEPES pH 7.5, 500 mM KCl.
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Covalent binding of Cas9-SNAP protein and BG-coupled
oligonucleotide
Repair oligo templates coupled to BG were incubated with Cas9-SNAP proteins on the same day
when the transfection is performed. BG-coupled oligos (2.2 pmols) were mixed with either SpCas9-
SNAP or SadCas9-SNAP (2.2 pmols) and incubated for 60 min at 30˚C. The negative controls (wild-
type Cas9 +BG oligo or Cas9-SNAP + unlabeled oligo) were treated in the same way.
SDS-PAGE gels
For confirming successful labeling of the Cas9-SNAP proteins with the BG-coupled oligonucleotides,
BG-coupled and uncoupled oligonucleotides were mixed with either SpCas9-SNAP, SadCas9-SNAP
or only the Cas9-SNAP proteins alone, reactions were incubated for one hour at 30˚C. For the
SNAP-Vista Green (NEB) substrate, the protein was incubated for 30 min on 30˚C in the dark. After
incubation, reactions (300 ng) were loaded on 6% SDS-PAGE gel and run at 80V for 160 min. Gels
that were containing BG-Vista Green (NEB, SNAP-Vista Green), were imaged prior to silver staining.
The green fluorescence signal of the SNAP-tag was detected with a UV transilluminator (Biorad).
Subsequently, silver staining was completed using the Pierce Silver Stain Kit (Thermo Scientific)
according to manufacturer instructions, and imaged with a UV transilluminator (Biorad).
Production of sgRNAs
sgRNAs were generated from DNA templates using the T7 RNA Polymerase (Roche) in vitro tran-
scription (IVT) kit. In short, sgRNA specific primers that also contain the T7 sequence were annealed
with a common reverse primer that contains the sequence of the sgRNA scaffold (final concentra-
tions 10 mM). DNA was purified with the QIAquick purification (Qiagen) kit and eluted in DEPC-
treated water. PCR products were run on agarose to estimate concentration and to confirm ampli-
con size. In vitro transcription was performed at 37˚C overnight. For purification, DNase I was added
to the sgRNAs and incubated for 15 min at 37˚C, and subsequently ethanol precipitation was per-
formed overnight at  20˚C. The sgRNAs were then further purified using RNA Clean and Concentra-
tors (Zymo Research). Before use, all sgRNAs were checked on denaturing 2% MOPS gels.
Complete sequences for all sgRNA protospacers, IVT primers and crRNAs can be found in
Supplementary file 1-Supplementary Table 1, 2 and 3, respectively.
Lentivirus production
HEK293T were PEI transfected with following plasmids: pNS19-LV-mutRFP-2A-eGFP, Pax2 and VSV-
G. After 12 hr, the supernatant was discarded and changed to DMEM plus 10% FBS. 24 and 72 hr
post-transfection, the media was collected and filtered through 0.45 mm filter and centrifuged at 20
000 G for 2:00 hr at 4˚C. The pellet was then resuspended in 1 ml of DMEM and stored at  80˚C.
Fluorescent reporter generation
HEK293T cells were transduced with a lentiviral vector carrying the fluorescent reporter construct.
Serial virus dilutions were used to isolate clonal populations using Puromycine selection (2 mg/ml) for
2 weeks.
Cell culture and reagents
HEK293T cells were obtained from ATCC and verified mycoplasma free (GATC Biotech). The
HEK293T reporter line was maintained in DMEM with GlutaMax (Gibco). Media was supplemented
with 10% FBS (Sigma), and 100 mg/mL Penicillin-Streptomycin (Gibco). K562 cells were obtained
from Sigma Aldrich, verified mycoplasma free and were maintained in RPMI 1640 medium with Glu-
taMax. Additional the medium supplemented with 10% FBS, and 100 mg/mL Penicillin-Streptomycin.
Cells were passaged three times per week. Cells were grown at 37˚C in a humidified 5% CO2 envi-
ronment. WT E14 mESC line (ATCC CRL-1821) was cultured in Dulbecco’s Modified Eagle Media
(DMEM) (Sigma-Aldrich), containing 15% of fetal bovine serum (FBS; Life Technologies), 100 U/mL
LIF (Millipore), 0.1 mM 2-ß-mercaptoethanol (Life Technologies) and 1% Penicillin/Streptomycin
(Gibco), on 0.2% gelatin-coated support in absence of feeder cells. The culture medium was
changed daily. Cells were grown at 37˚C in 8% CO2.
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Transfection reactions
HEK293T cells were seeded in 24-well plates at 120.000–140.000 cells per well, 1 day prior to trans-
fection. K562 cells were 6 hr prior to transfection distributed in 24 well plates at a density of
220.000–240.000 cells per well. On the day of transfection, RNP and RNPD complexes (2.2 pmols)
were complexed with sgRNA (3.88 pmols) in Opti-MEM (Invitrogen) and briefly vortexed, followed
by adding 3 ml the Lipofectamine 2000 reagent (Invitrogen) with Opti-MEM. The resulting mixture
was incubated for 15 min at room temperature to allow lipid particle formation. After 15 min of incu-
bation at room temperature, the mixture was dropped slowly into the well. One day post-transfec-
tion, cells were transferred to an 10 cm dish. mESCs were transfected into 6-well plate using
Lipofectamine 2000. Cells were plated 24 hr before transfection at a density of 20,000 cells/cm2 per
well and cultured in culture medium without streptomycin and penicillin. The medium was changed
to mESC culture medium 8 hr after transfection. Cells were collected 48 hr post-transfection.
Flow cytometry analysis
For flow cytometry analysis, HEK293T reporter cells were analysed 5 days after transfection. Cells
were trypsinized with TrypLE Express Enzym (Gibco), and resuspended in FACS buffer containing
PBS/1% FBS/1% EDTA. Sytox Red was added for the exclusion of dead cells. Data were acquired on
a BD LSR Fortessa cell analyser (Becton-Dickinson) and were further analysed using FlowJo software
(FlowJo 10.2). In all experiments, a minimum of 200.000 cells were analysed. Gating strategy: For-
ward versus side scatter (FSC-A vs SSC-A) gating was used to identify cells of interest. Doublets
were excluded using the forward scatter height versus forward scatter area density plot (FSC-H vs.
FSC-A). Live cells were gated based on Sytox-Red-negative staining. Live-gated cells were further
used to quantify the percentage of eGFP negative and turboRFP positive populations. Correction
efficiency (%) or (percentage of corrections in edited cells) was culculated as 100 * (eGFP/turboRFP
double positive population / (eGFP/turboRFP double negative population + eGFP/turboRFP double
positive population)).
Next Generation Sequencing
Transfected cells were collected by trypsinisation and were washed with PBS. PBS was discarded
and DNA extraction was preformed using DNeasy Blood and Tissue kit (Qiagen) following manufac-
turer’s protocol. The PCR amplicons flanking the targeted site were generated using NEBNext High-
Fidelity 2X PCR Master Mix (NEB), primers that were used are listed in Supplementary file 1-Sup-
plementary Table 5. PCR cycling conditions used were as follows: 1  98˚C for 3 min; 27  95˚C for
15 s, 65˚C for 15 s, 72˚C for 30 s; 1  72˚C for 5 min. Annealing temperature was optimized for each
primer set to ensure that a single amplicon was produced. PCR amplicons were purified by solid
phase reversible immobilization (SPRI) bead cleanup using Agencourt AMPure XP reagent (#A63881,
Beckmann-Coulter, Indianapolis, IN, USA), per the manufacturer’s instructions. For the generation of
the pooled sequencing libraries, the TruSeq (Illumina) Index Adaptor Sequences were added at the
second amplification step. The resulting Illumina libraries with Index Adaptors were purified with
AMPure XP reagent. Quality control for the final library was performed using the High sensitivity
D1000 ScreenTape at Agilent 2200 TapeStation. The libraries were sequenced using an Illumina
MiSeq sequencer (MiSeq Reagent Kit v2 (15M, 500 cycle kit) or MiSeq Reagent Micro Kit v2 (4M,
500 cycle kit), Illumina, San Diego, CA, USA). Sequences were received in the format of demulti-
plexed FASTQ files produced by Illumina’s bcl2fastq software (v2.19.0). Reads were merged with
Pear v0.9.8 (Zhang et al., 2014) and merged reads mapped to the amplicon sequences with BWA-
MEM v0.7.13-r1126 (Li, 2010). Unmerged reads were discarded. Sequence analysis was performed
in R using CrispRVariants v1.9.0 (Lindsay et al., 2016). Variants within the protospacer +PAM region
were analysed. Reads that align linearly and do not match the guide sequence are considered
‘Edited’. Percentage of edited alleles is calculated as 100* Edited reads/Total reads (excluding non-
linear alignments). Correction efficiency is 100* Perfectly corrected/Edited reads. The Scripts for
mapping sequencing data, counting mutations and generating plots are available at https://github.
com/HLindsay/Savic_CRISPR_HDR (Lindsay, 2018; copy archived at https://github.com/elifescien-
ces-publications/Savic_CRISPR_HDR) Fastq files have been uploaded to ArrayExpress
(Brazma et al., 2003), the accession number is E-MTAB-6808.
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Fluorescence microscopy
HEK293T reporter cells were imaged 7 days after transfection. Transfected cells were grown on
Poly-L-lysine coated 8-well glass chamber slides (Vitaris) to 80–90% confluence. Hoechst 33342
(Thermo Scientific, Pierce) was added in the cell culture media to a final concentration of 0.1 mg/ml,
and cells were incubated for 10 min at 37˚C, 5% CO2, prior to the image session. Confocal imaging
was performed using a Leica DMI8-CS (ScopeM) with a sCMOS camera (Hamamatsu Orca Flash 4.0).
The laser unit for confocal acquisition (AOBS system) contains 458, 477, 488, 496, 514 nm (Argon
laser), 405 nm, 561 nm, 633 nm. Images were acquired using Leica LAS X SP8 Version 1.0 software,
through using a 20  0.75 NA HC PLAN APO CS2 objective. Imaging conditions and intensity scales
were matched for images presented together. Images were analysed using the Leica LAS AF (Lite)
software version 3.3. Confocal images were processed using ImageJ software (Version 1.51 n).
Statistical analyses
Statistical analyses were conducted using Graphpad’s Prism7 software. A Mann-Whitney T-test was
conducted for two-sample analyses (P value style: 0.1234(ns), 0.0332(*), 0.0021(**)). All values are
shown as mean ± s.e.m of biological replicates. The number of biological replicates for each experi-
ment was detailed in the Figure Legends. Numerical data and the exact p values for all graphs have
been included in the Source data files.
Data availability
The data that support the findings of this study are available within the paper, Supplementary files,
Source data and NGS Fastq files have been uploaded to ArrayExpress.
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